Werner Meier
Technik-/Wissenschafts-/F&E-Leiter bei Revitope Oncology, Inc.
Profil
Werner Meier is associated with Revitope Oncology, Inc. as the Chief Scientific Officer & Director and with Revitope Ltd.
as a Director since 2019.
Aktive Positionen von Werner Meier
| Unternehmen | Position | Beginn |
|---|---|---|
Revitope Oncology, Inc.
 Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Revitope Ltd.
 Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Direktor/Vorstandsmitglied | 02.01.2019 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Revitope Oncology, Inc.
Revitope Oncology, Inc. Hospital/Nursing ManagementHealth Services Revitope Oncology, Inc. develops a programmable antibody circuit pipeline in particular redirecting T cells to tumors. The company was founded by Andrew Allen and Mark Cobbold and is headquartered in Cambridge, MA. | Health Services |
Revitope Ltd.
Revitope Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Revitope Ltd. is a British biotechnology company that operates as a developer of cancer therapies. The company is based in Hertfordshire, UK and is part of Revitope Oncology, Inc. | Commercial Services |
